A Review: The Global Burden of Breast Cancer

Authors

  • Mamta Kumari Department of Pharmacology, CT Institute of Pharmaceutical Sciences, Jalandhar, Punjab, India
  • Madan L. Kaushik Department of Pharmacology, CT Institute of Pharmaceutical Sciences, Jalandhar, Punjab, India

Abstract

 

Breast cancer is most common invasive cancer and the second main cause of death in women. In breast cancer the cancerous cells break out from inside the ducts and invade nearby tissue and increasing the chances of spreading the cancer to other body parts. Out of every 100 breast cancer patient, presently 4% are in the age group 20-30, 16% are in 30–40, 28% are in 40–50. Breast cancer has ranked number one cancer with age adjusted rate as high as 25.8 per 100,000 women and mortality 12.7 per 100,000 women. About 90% of breast cancer is due to genetic abnormalities. Most common genes implicated in breast cancer are BRCA1, BRCA2, p53 and CHEK2. Cancer detection in early stage is very important for the treatment. A mammogram is the screening test used to screen breast cancer. Treatments used for breast cancer are radiation therapy, chemotherapy, hormone therapy, targeted therapy and surgery. These treatments cause side effects like loss of appetite, hair loss, weight Gain, early menopause, bleeding, etc. The aim of this review is to find out the possible current mechanism and drug used to treatment of cancer. Nowadays the trend is alternative medicine such as plant and animal sources because these paths have less side effect and also inexpensive for cancer treatment. The breast cancer burden in worldwide can be reduced by choosing the alternative medicine or combination of drugs.

 

Keywords: Breast cancer, chemotherapy, radiation therapy, alternative medicine

Downloads

Published

2021-01-07

Issue

Vol. 7 No. 2 (2017)

Section

Research Article

License

Declaration and Copyright Transfer Form

(to be completed by authors)

I/ We, the undersigned author(s) of the submitted manuscript, hereby declare, that the above manuscript which is submitted for publication in the STM Journals(s), is not published already in part or whole (except in the form of abstract) in any journal or magazine for private or public circulation, and, is not under consideration of publication elsewhere.

  • I/We will not withdraw the manuscript after 1 week of submission as I have read the Author Guidelines and will adhere to the guidelines.
  • I/We Author(s ) have niether given nor will give this manuscript elsewhere for publishing after submitting in STM Journal(s).
  • I/ We have read the original version of the manuscript and am/ are responsible for the thought contents embodied in it. The work dealt in the manuscript is my/ our own, and my/ our individual contribution to this work is significant enough to qualify for authorship.
  •  I/We also agree to the authorship of the article in the following order:

Author’s name                                    

 

1. ________________

2. ________________

3. ________________

4. ________________

 

We  Author(s) tick this box and would request you to consider it as our signature as we agree to the terms of this Copyright Notice, which will apply to this submission if and when it is published by this journal.